Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Children With Low Grade Astrocytoma
NCT00003468Phase 2Completed
- Sponsor
- Burzynski Research Institute
- Start
- Jul 1996
- Primary completion
- Jul 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in astrocytoma, sponsored by Burzynski Research Institute. Started Jul 1996; status: completed.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
astrocytoma
Beyond the preview
Go deeper on NCT00003468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003468.